Yatharth Hospital & Trauma Care Services Limited
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
yatharthhospitals.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 171 Cr | 167 Cr | 178 Cr | 212 Cr | 218 Cr | 219 Cr | 232 Cr | 258 Cr | 279 Cr | 320 Cr | 342 Cr | 393 Cr |
| Operating expenses (approx.) | 126 Cr | 120 Cr | 131 Cr | 158 Cr | 163 Cr | 164 Cr | 175 Cr | 193 Cr | 215 Cr | 246 Cr | 262 Cr | 301 Cr |
| EBITDA | 46 Cr | 46 Cr | 47 Cr | 54 Cr | 55 Cr | 55 Cr | 57 Cr | 64 Cr | 65 Cr | 74 Cr | 80 Cr | 92 Cr |
| OPM % | 26.6% | 27.8% | 26.2% | 25.3% | 25.1% | 25.1% | 24.6% | 25.0% | 23.1% | 23.2% | 23.4% | 23.3% |
| Other income | 4 Cr | 5 Cr | 6 Cr | 4 Cr | 3 Cr | 4 Cr | 5 Cr | 9 Cr | 9 Cr | 8 Cr | 7 Cr | 4 Cr |
| Interest | 3 Cr | 0.17 Cr | 0.38 Cr | 3 Cr | 2 Cr | 2 Cr | 0.97 Cr | 0.19 Cr | 0.26 Cr | 1 Cr | 5 Cr | 7 Cr |
| Depreciation | 7 Cr | 8 Cr | 8 Cr | 11 Cr | 16 Cr | 17 Cr | 13 Cr | 15 Cr | 19 Cr | 24 Cr | 30 Cr | 28 Cr |
| Profit before tax | 40 Cr | 44 Cr | 44 Cr | 43 Cr | 40 Cr | 40 Cr | 49 Cr | 59 Cr | 55 Cr | 57 Cr | 52 Cr | 61 Cr |
| Tax % | 30.2% | 32.6% | 13.1% | 29.3% | 22.8% | 24.1% | 20.2% | 28.4% | 24.8% | 24.5% | 14.0% | 25.8% |
| Net profit | 28 Cr | 29 Cr | 38 Cr | 30 Cr | 31 Cr | 30 Cr | 39 Cr | 42 Cr | 41 Cr | 43 Cr | 45 Cr | 45 Cr |
| EPS (₹) | ₹3.80 | ₹3.83 | ₹4.85 | ₹3.54 | ₹3.59 | ₹3.57 | ₹4.37 | ₹4.36 | ₹4.28 | ₹4.71 | ₹4.93 | ₹4.88 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 671 Cr | 880 Cr | 1,207 Cr | Sign in for TTM |
| Operating expenses (approx.) | 491 Cr | 660 Cr | 915 Cr | Sign in for TTM |
| EBITDA | 180 Cr | 220 Cr | 292 Cr | Sign in for TTM |
| OPM % | 26.8% | 25.0% | 24.2% | Sign in for TTM |
| Other income | 16 Cr | 16 Cr | 26 Cr | Sign in for TTM |
| Interest | 9 Cr | 8 Cr | 7 Cr | Sign in for TTM |
| Depreciation | 29 Cr | 57 Cr | 88 Cr | Sign in for TTM |
| Profit before tax | 157 Cr | 172 Cr | 224 Cr | Sign in for TTM |
| Tax % | 27.0% | 24.0% | 23.8% | Sign in for TTM |
| Net profit | 114 Cr | 131 Cr | 170 Cr | Sign in for TTM |
| EPS (₹) | ₹14.46 | ₹14.72 | ₹18.20 | Sign in for TTM |
| Dividend payout % | 0.0% | 0.0% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 86 Cr | 96 Cr | 96 Cr |
| Reserves | 788 Cr | 1,509 Cr | 1,711 Cr |
| Borrowings | 83 Cr | — | 253 Cr |
| Other liabilities | 62 Cr | 94 Cr | 221 Cr |
| Total liabilities | 1,019 Cr | 1,731 Cr | 2,282 Cr |
| Fixed assets (net) | 381 Cr | 493 Cr | 902 Cr |
| CWIP | 0 Cr | 222 Cr | 102 Cr |
| Investments | 1 Cr | 74 Cr | 2 Cr |
| Inventories | 8 Cr | 21 Cr | 21 Cr |
| Trade receivables | 227 Cr | 302 Cr | 375 Cr |
| Cash & bank | 113 Cr | 362 Cr | 221 Cr |
| Other assets | 289 Cr | 257 Cr | 659 Cr |
| Total assets | 1,019 Cr | 1,731 Cr | 2,282 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operating activity | -3 Cr | 150 Cr | 205 Cr |
| Cash from investing | -226 Cr | -420 Cr | -598 Cr |
| Cash from financing | 304 Cr | 519 Cr | 254 Cr |
| Net cash flow | 75 Cr | 249 Cr | -140 Cr |
| Free cash flow (OCF − Capex) | -96 Cr | -161 Cr | -112 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | 17.4% | 10.9% | 11.2% |
| ROE % | 13.1% | 0.0% | 9.4% |
| Debtor days | 124 | 125 | 113 |
| Inventory days | 22 | 43 | 6 |
| Days payable | 80 | 59 | 33 |
| Cash conversion cycle | 66 | 108 | 86 |
| Debt / equity | 0.09 | — | 0.14 |
| Current ratio | 7.59 | 10.12 | 3.87 |
| Net debt / EBITDA | -0.16 | -1.64 | 0.11 |
Compare with peers
Loading peers…